Fibrinogen gamma chain (TG2) - Revision history

Bernadett at 11:37, 10 March 2015

2015-03-10T11:37:24Z

2008-06-12T13:16:06Z

2008-06-12T13:14:52Z

2007-08-30T12:14:41Z

2007-08-30T12:12:45Z

2007-08-30T12:10:04Z

2007-08-17T15:19:14Z

2007-07-25T07:52:23Z

2007-07-25T05:02:40Z

2007-07-23T10:43:14Z

@@ Line 1: / Line 1: @@
 {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
-! {{infobox header}}| '''{{PAGENAME}}'''
+! {infobox header}| '''{{PAGENAME}}'''
 |-
 | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Fibrinogen.JPG|200px|{{PAGENAME}}]]
@@ Line 48: / Line 48: @@
 | [[Minor TG2 reactive residues (Fibrinogen gamma)|Q144, Q195, Q239, Q311]] are minor substrate sites considering modification by TG2
 |-
-| {{infobox header}} |
+| {infobox header} |
 |-
 |}
 [[Category:Tissue transglutaminase|*]]

@@ Line 46: / Line 46: @@
 |-
 | Notes
-| [[Minor TG2 reactive residues (Fibrinogen gamma)|Q154, Q195, Q239, Q311]] are minor substrate sites considering modification by TG2
+| [[Minor TG2 reactive residues (Fibrinogen gamma)|Q144, Q195, Q239, Q311]] are minor substrate sites considering modification by TG2
 |-
 | {{infobox header}} |

@@ Line 46: / Line 46: @@
 |-
 | Notes
-| [[Minor TG2 reactive residues (Fibrinogen gamma)|Q145, Q195, Q239, Q311]] are minor substrate sites considering modification by TG2
+| [[Minor TG2 reactive residues (Fibrinogen gamma)|Q154, Q195, Q239, Q311]] are minor substrate sites considering modification by TG2
 |-
 | {{infobox header}} |

@@ Line 2: / Line 2: @@
 ! {{infobox header}}| '''{{PAGENAME}}'''
 |-
-| align="center" colspan="2" bgcolor="#ffffff" | [[Image:{{PAGENAME}}.png|200px|{{PAGENAME}}]]
+| align="center" colspan="2" bgcolor="#ffffff" | [[Image:Fibrinogen.JPG|200px|{{PAGENAME}}]]
 |-
 | Substrate peptide name

@@ Line 46: / Line 46: @@
 |-
 | Notes
-| Q145, Q195, Q239, Q311 are minor substrate sites considering modification by TG2
+| [[Minor TG2 reactive residues (Fibrinogen gamma)|Q145, Q195, Q239, Q311]] are minor substrate sites considering modification by TG2
 |-
 | {{infobox header}} |

@@ Line 23: / Line 23: @@
 |-
 | Reactive glutamines
-| Q398
+| [[TG2 reactive residues (Fibrinogen gamma)|Q398]]
 |-
 | Reactive lysines

@@ Line 5: / Line 5: @@
 |-
 | Substrate peptide name
-| {{PAGENAME}}
+| Fibrinogen gamma chain
 |-
 | Synonyms

@@ Line 36: / Line 36: @@
 |-
 | Surface accessibility
-| [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] pdf
+| [http://gibk21.bse.kyutech.ac.jp/asaview/all/1fid.pdf ASAView] pdf
 |-
 | Disorder prediction

← Older revision	Revision as of 05:02, 25 July 2007
(No difference)